CF
44
-7
FMC
43
-7
HIG
62
8
SNA
75
5
USB
54
8
LB
49
4
L
59
8
COST
57
3
PX
69
3
AN
55
8
DOV
69
8
CHD
42
-3
FFIV
69
2
AVY
47
-6
AMGN
46
4
FITB
65
13
CSCO
63
3
WY
50
-3
M
39
9
C
64
10
CF
44
-7
FMC
43
-7
HIG
62
8
SNA
75
5
USB
54
8
LB
49
4
L
59
8
COST
57
3
PX
69
3
AN
55
8
DOV
69
8
CHD
42
-3
FFIV
69
2
AVY
47
-6
AMGN
46
4
FITB
65
13
CSCO
63
3
WY
50
-3
M
39
9
C
64
10
Financhill
Back

Checkpoint Therapeutics Quote, Financials, Valuation and Earnings

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Sell
39

CKPT
Checkpoint Therapeutics

Last Price:
3.46
Seasonality Move:
-5.4%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Checkpoint Therapeutics Price Quote

$3.46
+0.09 (+2.67%)
(Updated: November 7, 2024 at 5:55 PM ET)

Checkpoint Therapeutics Key Stats

Sell
39
Checkpoint Therapeutics (CKPT) is a Sell
Day range:
$3.28 - $3.49
52-week range:
$1.36 - $3.97
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
745K
Avg. volume:
901.2K
1-year change:
73.71%
Market cap:
$148.6M
Revenue:
$103K
EPS:
$-1.9

How Much Does Checkpoint Therapeutics Make?

Data Unavailable

Is Checkpoint Therapeutics Growing As A Company?

Checkpoint Therapeutics Stock Price Performance

What Is Checkpoint Therapeutics 52-Week High & Low?

Checkpoint Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Checkpoint Therapeutics?

Is Checkpoint Therapeutics Cash Flow Positive?

  • What Is CKPT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$34.3M
  • What Is Checkpoint Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $31.8M
  • What Is Checkpoint Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Checkpoint Therapeutics Return On Invested Capital

Data Unavailable

Checkpoint Therapeutics Earnings Date & Stock Price

Checkpoint Therapeutics Competitors

Checkpoint Therapeutics Dividend Yield

Checkpoint Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 32.26% 296.9%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 17.00
Upside from Last Price: 404.45%

Major Shareholders

  • How many CKPT shares are owned by institutional investors?
    12.2M CKPT shares are owned by institutional investors
  • How many CKPT shares are owned by insiders?
    3.2M CKPT shares are owned by insiders